Clinical Trials Directory

Trials / Completed

CompletedNCT00097253

The Effects of Smell on Mood and Physical Responses

Psychoneuroimmunology and Mind-Body Medicine: Olfaction, Mood, and Physiological Responses

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
56 (actual)
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
All
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the body's response to relaxing and stimulating fragrances commonly used in aromatherapy.

Detailed description

Despite aromatherapy's popularity, efficacy data are scant, and potential mechanisms are controversial. This randomized controlled trial examined the psychological, autonomic, endocrine, and immune consequences of one purported relaxant odor (lavender), one stimulant odor (lemon), and a no-odor control (water), before and after a stressor (cold pressor); 56 healthy men and women were exposed to each of the odors during three separate visits. To assess the effects of expectancies, participants randomized to the "blind" condition were given no information about the odors they would smell; "primed" individuals were told what odors they would smell during the session, and what changes to expect. Experimenters were blind. In each case we measured several different aspects of the cellular immune response, as well as skin barrier repair following tape stripping. This design allowed us to examine the ability of the odors to modulate endocrine and immune function, and health-relevant cutaneous responses.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExposure to relaxant and stimulant odorsA yellow-tinted cotton ball containing 100 ml of the essential oil or distilled water was taped between the nose and upper lip on top of a piece of surgical tape; use of the barrier tape avoided percutaneous absorption . This method provided continuous and uniform exposure across subjects that would not have been possible with ambient room inhalation, and helped maintain experimenter blindness.

Timeline

Start date
2005-08-01
Primary completion
2006-03-01
Completion
2006-03-01
First posted
2004-11-22
Last updated
2010-02-18
Results posted
2010-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00097253. Inclusion in this directory is not an endorsement.